| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.403 | 20.775 | 22.311 | 12.975 | 71.752 | 45.440 | 38.664 | 30.902 | 32.448 | 93.723 |
| Total Income - EUR | 12.171 | 21.100 | 22.391 | 12.994 | 71.764 | 45.532 | 38.893 | 31.195 | 32.609 | 93.723 |
| Total Expenses - EUR | 14.810 | 14.165 | 18.591 | 18.813 | 27.812 | 28.023 | 27.677 | 25.457 | 41.486 | 57.061 |
| Gross Profit/Loss - EUR | -2.640 | 6.935 | 3.800 | -5.820 | 43.952 | 17.509 | 11.216 | 5.738 | -8.877 | 36.662 |
| Net Profit/Loss - EUR | -2.983 | 6.302 | 3.128 | -6.210 | 41.800 | 16.466 | 10.230 | 4.769 | -8.877 | 30.668 |
| Employees | 2 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Bioelle Consultancy Services Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 626 | 296 | 196 | 110 | 21.649 | 70.930 | 64.992 | 27.338 | 22.853 | 26.584 |
| Current Assets | 2.150 | 6.229 | 3.579 | 12.362 | 39.573 | 41.621 | 37.085 | 33.611 | 37.961 | 53.799 |
| Inventories | 1.275 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.421 | 19.843 |
| Receivables | 604 | 0 | 3.082 | 2.783 | 32.977 | 31.024 | 15.099 | 32.370 | 29.602 | 29.416 |
| Cash | 271 | 6.229 | 497 | 9.579 | 6.596 | 10.597 | 21.985 | 1.241 | 939 | 4.540 |
| Shareholders Funds | -19.016 | -12.520 | -9.180 | -15.221 | 26.873 | 42.830 | 53.055 | 45.728 | 36.712 | 64.989 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 21.792 | 19.044 | 12.955 | 27.693 | 34.348 | 69.943 | 49.368 | 15.221 | 24.358 | 15.486 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Bioelle Consultancy Services Srl